Applied DNA Sciences Analyst Ratings
Applied DNA Sciences Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 08/14/2023 | 156.41% | HC Wainwright & Co. | $5 → $4 | Maintains | Buy |
| 07/14/2023 | 220.51% | HC Wainwright & Co. | → $5 | Reiterates | Buy → Buy |
| 05/12/2023 | 220.51% | HC Wainwright & Co. | → $5 | Reiterates | Buy → Buy |
| 05/08/2023 | 220.51% | HC Wainwright & Co. | → $5 | Reiterates | → Buy |
| 03/30/2023 | 220.51% | HC Wainwright & Co. | → $5 | Reiterates | → Buy |
| 03/23/2023 | 220.51% | HC Wainwright & Co. | → $5 | Reiterates | → Buy |
| 02/10/2023 | 220.51% | HC Wainwright & Co. | → $5 | Reiterates | → Buy |
| 12/15/2022 | 220.51% | HC Wainwright & Co. | $8 → $5 | Maintains | Buy |
| 08/08/2022 | 412.82% | HC Wainwright & Co. | $4 → $8 | Maintains | Buy |
| 05/16/2022 | 156.41% | HC Wainwright & Co. | $6 → $4 | Maintains | Buy |
| 02/11/2022 | 284.62% | HC Wainwright & Co. | $8 → $6 | Maintains | Buy |
| 08/13/2021 | 605.13% | HC Wainwright & Co. | $13 → $11 | Maintains | Buy |
| 04/22/2021 | 733.33% | HC Wainwright & Co. | $14 → $13 | Maintains | Buy |
| 02/12/2021 | 1438.46% | Roth Capital | → $24 | Initiates Coverage On | → Buy |
| 01/14/2021 | 797.44% | HC Wainwright & Co. | $18 → $14 | Maintains | Buy |
| 01/11/2021 | 1053.85% | HC Wainwright & Co. | $12 → $18 | Maintains | Buy |
| 11/30/2020 | 1182.05% | HC Wainwright & Co. | $22 → $20 | Maintains | Buy |
| 07/20/2020 | 1310.26% | HC Wainwright & Co. | $18 → $22 | Maintains | Buy |
| 07/02/2020 | 1053.85% | HC Wainwright & Co. | → $18 | Initiates Coverage On | → Buy |
| 11/22/2019 | 412.82% | Maxim Group | → $8 | Upgrades | Hold → Buy |
| 08/15/2018 | 92.31% | Maxim Group | $5 → $3 | Maintains | Buy |
| 日期 | 上行/下行 | 分析公司 | 目標價格變化 | 評級變化 | 上一次/當前評級 |
|---|---|---|---|---|---|
| 2023年08月14日 | 156.41% | HC Wainwright公司 | $5→$4 | 維護 | 買 |
| 07/14/2023 | 220.51% | HC Wainwright公司 | →$5 | 重申 | 購買→購買 |
| 2023年05月12日 | 220.51% | HC Wainwright公司 | →$5 | 重申 | 購買→購買 |
| 05/08/2023 | 220.51% | HC Wainwright公司 | →$5 | 重申 | →購買 |
| 03/30/2023 | 220.51% | HC Wainwright公司 | →$5 | 重申 | →購買 |
| 03/23/2023 | 220.51% | HC Wainwright公司 | →$5 | 重申 | →購買 |
| 02/10/2023 | 220.51% | HC Wainwright公司 | →$5 | 重申 | →購買 |
| 2022年12月15日 | 220.51% | HC Wainwright公司 | $8→$5 | 維護 | 買 |
| 2022/08/08 | 412.82% | HC Wainwright公司 | $4→$8 | 維護 | 買 |
| 05/16/2022 | 156.41% | HC Wainwright公司 | $6→$4 | 維護 | 買 |
| 02/11/2022 | 284.62% | HC Wainwright公司 | $8→$6 | 維護 | 買 |
| 2021/08/13 | 605.13% | HC Wainwright公司 | $13→$11 | 維護 | 買 |
| 04/22/2021 | 733.33% | HC Wainwright公司 | $14→$13 | 維護 | 買 |
| 02/12/2021 | 1438.46% | 羅斯資本 | →$24 | 開始承保 | →購買 |
| 2021/01/14 | 797.44% | HC Wainwright公司 | $18→$14 | 維護 | 買 |
| 2021/11/01 | 1053.85% | HC Wainwright公司 | $12→$18 | 維護 | 買 |
| 11/30/2020 | 1182.05% | HC Wainwright公司 | $22→$20 | 維護 | 買 |
| 07/20/2020 | 1310.26% | HC Wainwright公司 | $18→$22 | 維護 | 買 |
| 07/02/2020 | 1053.85% | HC Wainwright公司 | →$18 | 開始承保 | →購買 |
| 2019年11月22日 | 412.82% | Maxim集團 | →$8 | 升級 | 持有→購買 |
| 2018年08月15日 | 92.31% | Maxim集團 | $5→$3 | 維護 | 買 |
What is the target price for Applied DNA Sciences (APDN)?
應用DNA科學(APDN)的目標價格是多少？
The latest price target for Applied DNA Sciences (NASDAQ: APDN) was reported by HC Wainwright & Co. on August 14, 2023. The analyst firm set a price target for $4.00 expecting APDN to rise to within 12 months (a possible 156.41% upside). 8 analyst firms have reported ratings in the last year.
應用DNA科學公司(納斯達克代碼：APDN)的最新目標價是由HC Wainwright&Co.於2023年8月14日報道的。這家分析公司將目標價定為4美元，預計亞太地區的價格將在12個月內上漲(可能上漲156.41%)。去年有8家分析公司公佈了評級。
What is the most recent analyst rating for Applied DNA Sciences (APDN)?
應用DNA科學(APDN)的最新分析師評級是多少？
The latest analyst rating for Applied DNA Sciences (NASDAQ: APDN) was provided by HC Wainwright & Co., and Applied DNA Sciences maintained their buy rating.
對應用DNA科學公司(納斯達克代碼：APDN)的最新分析師評級由HC Wainwright&Co.提供，應用DNA科學公司維持其買入評級。
When is the next analyst rating going to be posted or updated for Applied DNA Sciences (APDN)?
應用DNA科學(APDN)的下一次分析師評級將於何時發佈或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Applied DNA Sciences, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Applied DNA Sciences was filed on August 14, 2023 so you should expect the next rating to be made available sometime around August 14, 2024.
分析師在進行了廣泛的研究後得出股票評級，其中包括查閱公共財務報表，與應用DNA科學公司的高管和客戶交談，以及收聽收益電話會議。大多數分析師每三個月就會這樣做一次，所以你每年應該會得到每家公司每家公司的4個評級。應用DNA科學的上一次評級是在2023年8月14日提交的，所以你應該預計下一次評級將在2024年8月14日左右提供。
Is the Analyst Rating Applied DNA Sciences (APDN) correct?
分析師對應用DNA科學(APDN)的評級正確嗎？
While ratings are subjective and will change, the latest Applied DNA Sciences (APDN) rating was a maintained with a price target of $5.00 to $4.00. The current price Applied DNA Sciences (APDN) is trading at is $1.56, which is out of the analyst's predicted range.
雖然評級是主觀的，並將發生變化，但最新的應用DNA科學(APDN)評級保持不變，目標價在5.00美元至4.00美元之間。應用DNA科學公司(APDN)目前的交易價格為1.56美元，超出了分析師的預測範圍。